CPHI Frankfurt

• WHEN: Monday, October 27 | 12:30 - 5:30 p.m
• WHERE: SK1 Business Club, Neue Mainzer Str. 52-58, 60311 Frankfurt, Germany
  
• PARTICIPATION FEE: Free of charge

Lipids are among the most clinically significant excipients in drug delivery systems, playing a particularly vital role in nucleic acid-based therapies e.g. mRNA vaccines. As a trusted CDMO partner, Evonik brings decades of expertise in both the synthesis of these excipients and the clinical manufacturing of lipid-based drug delivery systems.

The workshop will focus on the evolving role of lipids in the drug delivery, with key insights into critical success factors. Beyond scaling challenges of lipid nanoparticles, we will discuss their critical role in enabling RNA-based therapies.

We are delighted to welcome our guest speakers from Ethris GmbH, Knauer GmbH and NovoArc who will present on innovative and exciting delivery technologies.

• WHEN: Wednesday, October 29 | 2:05 - 2:30 p.m
• WHERE: Sustainable Futures Theatre (Hall 4)
• WHO: Dr. Andreas Jakob (Customer Project Manager Lipids) | Evonik Health Care)

Be sure to catch the presentation on PhytoSquene®, Evonik's plant-based squalene for parenteral applications such as vaccine adjuvants by our expert Rima Jaber. In her talk, you can learn about how PhytoSquene® offers pharmaceutical companies the opportunity to improve the safety and sustainability of their products. She will also present data from a study that compares the physical chemical attributes and in vitro toxicity effects of GMP-grade PhytoSquene® with animal-derived squalene.